Updated Jul 16, 2026
Raben David has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $942K.
David Raben serves as the Chief Medical Officer at Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing bifunctional therapies for solid tumors. He has been involved in the company's efforts to advance its lead program, ficerafusp alfa.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-28 | BCAX | Bicara Therapeutics Inc. | S — Open-market sale | 5.5K | $22.88 | $126K |
| 2026-04-28 | BCAX | Bicara Therapeutics Inc. | M — Option exercise | 5.5K | $3.79 | $21K |
| 2026-03-26 | BCAX | Bicara Therapeutics Inc. | S — Open-market sale [10b5-1] | 5.5K | $18.95 | $104K |
| 2026-03-26 | BCAX | Bicara Therapeutics Inc. | M — Option exercise [10b5-1] | 5.5K | $3.79 | $21K |
| 2026-03-06 | BCAX | Bicara Therapeutics Inc. | S — Open-market sale [10b5-1] | 16.3K | $18.52 | $302K |
| 2026-03-06 | BCAX | Bicara Therapeutics Inc. | M — Option exercise [10b5-1] | 16.3K | $3.79 | $62K |
| 2026-03-06 | BCAX | Bicara Therapeutics Inc. | S — Open-market sale [10b5-1] | 200 | $18.45 | $4K |
| 2026-03-06 | BCAX | Bicara Therapeutics Inc. | M — Option exercise [10b5-1] | 200 | $3.79 | $758 |
| 2025-10-09 | BCAX | Bicara Therapeutics Inc. | S — Open-market sale | 22.0K | $18.45 | $406K |
| 2025-10-09 | BCAX | Bicara Therapeutics Inc. | M — Option exercise | 22.0K | $3.79 | $83K |
David Raben serves as the Chief Medical Officer at Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing bifunctional therapies for solid tumors. He has been involved in the company's efforts to advance its lead program, ficerafusp alfa.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($942K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Raben David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.